Skip to main content
. 2018 Oct 15;2018:7402947. doi: 10.1155/2018/7402947

Table 1.

In vitro animal studies included.

Reference Author Subjects Pathway involved Results
[3] J. Wu et al. (2018) New Zealand white rabbit chondrocytes PRP and Wnt/ β-catenin A lower expression level of WNT1 and β-catenin than in another group treated with IL-1β was observed

[4] C.Lietman et al. (2018) OA-induced murine model synovial fibroblasts and chondrocytes XAV-939 After it was injected inside the joint, a reduction of the cartilage degradation and synovial inflammation was observed

[6] L. Lodewyckx et al. (2012) Cell culture (ATDC5) and mouse ribcage and tibial plateau chondrocytes from Frzb−/− and wild type mices Wnt/β-catenin Overexpression of FRZB coupled with an up-regulation of aggrecan and Col2a1 and down-regulation of Col3a1 and Col5a1. FRZB is in strict relationship to Wnt pathway

[7] T. Yuasa et al. (2008) New Zealand rabbit articular chondrocytes and guinea pig knee chondrocytes Wnt/β-catenin Wnt/beta-catenin signalling is a powerful stimulator of chondrocyte matrix catabolic action and may be part of mechanisms leading to excessive remodelling and degradation of cartilage matrix in age-associated joint pathologies

[8] M. Zhu et al. (2009) Adult Col2a1-CreERT2 transgenic mice chondrocytes β-catenin Activation of beta-catenin signalling in articular chondrocytes in adult mice leads to the premature chondrocyte differentiation and the development of an OA-like phenotype.

[10] Y. Tamamura et al. (2005) transgenic mice expressing a fusion mutant protein of β-catenin and LEF (CA-LEF) in nascent chondrocytes δ-β-Catenin Increase of proteins involved in cartilage matrix degradation (MMP-13, ADAMTS-4, ADAMTS-5 and RUNX-2)

[11] Shi et al. (2016) Sprague-Dawley rats (n=24) articular chondrocytes WNT5A Silencing WNT5A mRNA prevented degradation of COL2

[15] Wang D. et al (2018) 100 BALB/c transgenic mice osteoclasts PRP/RANKL/Wnt The study indicated that PRP inhibits osteoclast differentiation through activation of the Wnt pathway and inhibiting RANKL